It also reduces cholesterol and triglycerides
Personalized Care with GLP-1 Therapy Compounding GLP-1 compounding refers to the process of creating customized formulations of glucagon-like peptide-1 (GLP-1) receptor agonists by compounding pharmacies
Additionally, GIP receptor expression in hypothalamic regions and oligodendrocytes suggests central nervous system actions that may synergize with GLP-1 to reduce appetite and food intake while potentially mitigating GLP-1-associated nausea, thereby improving treatment tolerability [36,41,42]
3.2 Systematic reviews and meta-analyses: three tiers of critical evidence Existing secondary research can be broadly categorized into three tiers: (i) PCOS-specific meta-analyses of RCTs (primarily focusing on weight, metabolism, and select endocrine markers)
However, research has begun to discover applications for these therapies beyond cardiometabolic health due to their systemic antiinflammatory properties
Comparing tirzepatide to GLP1RAs using the results of prior comparison trials is challenging